{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:58:28Z","timestamp":1770742708468,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016259","name":"Viatris Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["chestpulmonary.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST Pulmonary"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.chpulm.2024.100105","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T18:13:25Z","timestamp":1726078405000},"page":"100105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety, Efficacy, and Feasibility of Nebulized Long-Acting Bronchodilators vs\u00a0Short-Acting Bronchodilators in Hospitalized Patients With Acute Exacerbations of COPD"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3621-2422","authenticated-orcid":false,"given":"Rajiv","family":"Dhand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6730-7275","authenticated-orcid":false,"given":"Samuel","family":"Treat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0926-7516","authenticated-orcid":false,"given":"Scott","family":"Elder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Church","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Faircloth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8507-7426","authenticated-orcid":false,"given":"Gulsah","family":"Onar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Eric","family":"Heidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6180-3999","authenticated-orcid":false,"given":"Isaac","family":"Biney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Valdes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6008-6342","authenticated-orcid":false,"given":"Milind","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Fuerst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Cusick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.chpulm.2024.100105_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","article-title":"Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis","volume":"10","author":"Adeloye","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.chpulm.2024.100105_bib3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.chpulm.2024.100105_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/15412555.2011.650239","article-title":"Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality","volume":"9","author":"Perera","year":"2012","journal-title":"COPD"},{"key":"10.1016\/j.chpulm.2024.100105_bib5","first-page":"235","article-title":"The clinical and economic burden of chronic obstructive pulmonary disease in the USA","volume":"5","author":"Guarascio","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.chpulm.2024.100105_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/COPD.S173595","article-title":"Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD","volume":"14","author":"Hanania","year":"2018","journal-title":"Int J COPD"},{"key":"10.1016\/j.chpulm.2024.100105_bib8","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2147\/COPD.S157654","article-title":"Revefenacin: a once-daily, long-acting bronchodilator for nebulized treatment of COPD","volume":"14","author":"Donohue","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"13","key":"10.1016\/j.chpulm.2024.100105_bib9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/ajhp\/zxab154","article-title":"Revefenacin, a once-daily, long-acting muscarinic antagonist, for nebulized maintenance therapy in patients with chronic obstructive pulmonary disease","volume":"78","author":"Hvisdas","year":"2021","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.chpulm.2024.100105_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.15326\/jcopdf.7.2.2019.0154","article-title":"Safety and efficacy of revefenacin and formoterol in sequence and combination via a standard jet nebulizer in patients with chronic obstructive pulmonary disease: a phase 3b, randomized, 42-day study","volume":"7","author":"Siler","year":"2020","journal-title":"COPD"},{"issue":"11","key":"10.1016\/j.chpulm.2024.100105_bib11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.rmed.2006.03.007","article-title":"Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study","volume":"100","author":"Di Marco","year":"2006","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.chpulm.2024.100105_bib12","first-page":"1678","article-title":"Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs","volume":"53","author":"Drescher","year":"2008","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.chpulm.2024.100105_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rmed.2007.10.007","article-title":"Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients","volume":"102","author":"Gross","year":"2008","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.chpulm.2024.100105_bib14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s12325-009-0080-z","article-title":"Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease","volume":"26","author":"Tashkin","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.chpulm.2024.100105_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/COPD.S52557","article-title":"Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD","volume":"8","author":"Bollu","year":"2013","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chpulm.2024.100105_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/COPD.S122354","article-title":"Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD","volume":"12","author":"Bishwakarma","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chpulm.2024.100105_bib17","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2147\/COPD.S134145","article-title":"Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol","volume":"12","author":"Ganapathy","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"10.1016\/j.chpulm.2024.100105_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2146\/ajhp160979","article-title":"Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease","volume":"75","author":"Amin","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.chpulm.2024.100105_bib19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1513\/AnnalsATS.201407-311OC","article-title":"Use and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary disease","volume":"11","author":"Lindenauer","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.chpulm.2024.100105_bib20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.150.5.7952549","article-title":"The influence of age, diagnosis, and gender on proper use of metered-dose inhalers","volume":"150","author":"Goodman","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chpulm.2024.100105_bib21","first-page":"1313","article-title":"Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler","volume":"50","author":"Geller","year":"2005","journal-title":"Respir Care"},{"key":"10.1016\/j.chpulm.2024.100105_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/rmed.2001.1292","article-title":"Survey of patients\u2019 views of domiciliary nebulizer treatment for chronic lung disease","volume":"96","author":"Barta","year":"2002","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.chpulm.2024.100105_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02850087","article-title":"The role of nebulized inhaled corticosteroid therapy in adult patients with asthma and chronic obstructive pulmonary disease","volume":"22","author":"Marcus","year":"2005","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.chpulm.2024.100105_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/15412555.2011.630047","article-title":"The role of nebulized therapy in the management of COPD: evidence and recommendations","volume":"9","author":"Dhand","year":"2012","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.chpulm.2024.100105_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MCP.0000000000000941","article-title":"Recent advances predict a bright future for nebulizers","volume":"29","author":"Troy","year":"2023","journal-title":"Curr Opin Pulm Med"},{"issue":"20","key":"10.1016\/j.chpulm.2024.100105_bib26","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.chpulm.2024.100105_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12325-010-0017-6","article-title":"The short, the long, and the \u201cultra-long\u201d: why duration of bronchodilator action matters in chronic obstructive pulmonary disease","volume":"27","author":"Beeh","year":"2010","journal-title":"Adv Ther"},{"key":"10.1016\/j.chpulm.2024.100105_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40749-015-0008-8","article-title":"Lung hyperinflation in COPD: applying physiology to clinical practice","volume":"1","author":"O\u2019Donnell","year":"2015","journal-title":"COPD Research and Practice"},{"key":"10.1016\/j.chpulm.2024.100105_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4104\/pcrj.2013.00025","article-title":"No room to breathe: the importance of lung hyperinflation in COPD","volume":"22","author":"Thomas","year":"2013","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.chpulm.2024.100105_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3810\/pgm.2014.09.2808","article-title":"Examining the role of activity, exercise, and pharmacology in mild COPD","volume":"126","author":"O\u2019Donnell","year":"2014","journal-title":"Postgrad Med"},{"key":"10.1016\/j.chpulm.2024.100105_bib31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.rmed.2015.05.012","article-title":"Indacaterol vs\u00a0tiotropium in COPD patients classified as GOLD A and B","volume":"109","author":"Mahler","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.chpulm.2024.100105_bib32","article-title":"Effects of combined tiotropium\/olodaterol on inspiratory capacity and exercise endurance in COPD","volume":"49","author":"O\u2019Donnell","year":"2017","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.chpulm.2024.100105_bib33","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1517\/14740338.2015.1093621","article-title":"The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease","volume":"14","author":"Tashkin","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"1A","key":"10.1016\/j.chpulm.2024.100105_bib34","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/S0002-9343(96)80037-4","article-title":"Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease","volume":"29;100","author":"Colice","year":"1996","journal-title":"Am J Med"},{"issue":"1A","key":"10.1016\/j.chpulm.2024.100105_bib35","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1016\/S0002-9343(96)80109-4","article-title":"Results of a multicenter study of nebulized inhalant bronchodilator solutions","volume":"100","author":"Tashkin","year":"1996","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.chpulm.2024.100105_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.15326\/jcopdf.5.2.2017.0169","article-title":"Spirometry in hospitalized patients with\u00a0acute exacerbation of COPD accurately predicts post discharge airflow obstruction","volume":"5","author":"Loh","year":"2017","journal-title":"COPD"},{"issue":"3","key":"10.1016\/j.chpulm.2024.100105_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194983","article-title":"Reliability and usefulness of spirometry performed during admission for COPD exacerbation","volume":"13","author":"Fern\u00e1ndez-Villar","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.chpulm.2024.100105_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/15412555.2015.1078784","article-title":"Predictors of change in dyspnea level in acute exacerbations of COPD","volume":"13","author":"Garcia-Gutierrez","year":"2016","journal-title":"COPD"},{"key":"10.1016\/j.chpulm.2024.100105_bib39","first-page":"216","article-title":"Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma","volume":"26","author":"Kendrick","year":"2000","journal-title":"J\u00a0Emerg Nurs"},{"issue":"4 pt 1","key":"10.1016\/j.chpulm.2024.100105_bib40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1164\/ajrccm\/141.4_Pt_1.909","article-title":"Comparison of scales used to quantitate the sense of effort to breathe in patients with chronic obstructive pulmonary disease","volume":"141","author":"Muza","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.chpulm.2024.100105_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/2049-6958-5-3-202","article-title":"Measures of dyspnea in pulmonary rehabilitation","volume":"5","author":"Crisafulli","year":"2010","journal-title":"Multidiscip Respir Med"},{"issue":"5","key":"10.1016\/j.chpulm.2024.100105_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/15412555.2018.1537366","article-title":"Minimal important and detectable differences of respiratory measures in outpatients with AECOPD","volume":"15","author":"Oliveira","year":"2018","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.chpulm.2024.100105_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/COPD-200050655","article-title":"Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale","volume":"2","author":"Ries","year":"2005","journal-title":"COPD"},{"issue":"11","key":"10.1016\/j.chpulm.2024.100105_bib45","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/SMJ.0b013e3182334606","article-title":"An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations","volume":"104","author":"Woods","year":"2011","journal-title":"South Med J"},{"issue":"3","key":"10.1016\/j.chpulm.2024.100105_bib46","first-page":"242","article-title":"Physicochemical stability and compatibility of revefenacin (LAMA) and formoterol fumarate (LABA) inhalation solution admixture","volume":"24","author":"Ngim","year":"2020","journal-title":"Int J Pharm Compd"}],"container-title":["CHEST Pulmonary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789224000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789224000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T06:07:35Z","timestamp":1735279655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949789224000710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2949789224000710"],"URL":"https:\/\/doi.org\/10.1016\/j.chpulm.2024.100105","relation":{},"ISSN":["2949-7892"],"issn-type":[{"value":"2949-7892","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, Efficacy, and Feasibility of Nebulized Long-Acting Bronchodilators vs\u00a0Short-Acting Bronchodilators in Hospitalized Patients With Acute Exacerbations of COPD","name":"articletitle","label":"Article Title"},{"value":"CHEST Pulmonary","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chpulm.2024.100105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100105"}}